{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T07:35:57Z","timestamp":1788593757488,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.oret.2024.05.014","type":"journal-article","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T23:44:21Z","timestamp":1716853461000},"page":"1093-1099","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Screen Failures in Clinical Trials in Retina"],"prefix":"10.1016","volume":"8","author":[{"given":"Nasiq","family":"Hasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunaal","family":"Mehrotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7422-802X","authenticated-orcid":false,"given":"Carl J.","family":"Danzig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0654-0668","authenticated-orcid":false,"given":"David A.","family":"Eichenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Ewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Regillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5435-7369","authenticated-orcid":false,"given":"Bita","family":"Momenaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7467-9947","authenticated-orcid":false,"given":"Veeral S.","family":"Sheth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Lally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Chhablani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2024.05.014_bib1","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1111\/1471-0528.15199","article-title":"Randomised controlled trials\u2014the gold standard for effectiveness research: study design: randomised controlled trials","volume":"125","author":"Hariton","year":"2018","journal-title":"BJOG"},{"issue":"15","key":"10.1016\/j.oret.2024.05.014_bib3","article-title":"Lessons from the other side of clinical trial accrual: screen failures at the Josephine Ford Cancer Center\/Henry Ford Health System in 2011","volume":"29","author":"Wang","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.oret.2024.05.014_bib4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/009286151104500307","article-title":"Measuring the incidence, causes, and repercussions of protocol amendments","volume":"45","author":"Getz","year":"2011","journal-title":"Drug Information J"},{"key":"10.1016\/j.oret.2024.05.014_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.oret.2024.05.014_bib6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13063-017-2413-6","article-title":"Development of a framework to improve the process of recruitment to randomised controlled trials (RCTs): the SEAR (Screened, Eligible, Approached, Randomised) framework","volume":"19","author":"Wilson","year":"2018","journal-title":"Trials"},{"key":"10.1016\/j.oret.2024.05.014_bib7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1200\/JOP.2012.000646","article-title":"Effort required in eligibility screening for clinical trials","volume":"8","author":"Penberthy","year":"2012","journal-title":"J\u00a0Oncol Pract"},{"key":"10.1016\/j.oret.2024.05.014_bib8","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1177\/0883073813495959","article-title":"Clinical trials in rare disease: challenges and opportunities","volume":"28","author":"Augustine","year":"2013","journal-title":"J\u00a0Child Neurol"},{"key":"10.1016\/j.oret.2024.05.014_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2022.100266","article-title":"Characteristics of design and analysis of ophthalmic randomized controlled trials: a review of ophthalmic papers 2020-2021","volume":"3","author":"Dong","year":"2023","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.oret.2024.05.014_bib11","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.conctc.2018.08.001","article-title":"Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review","volume":"11","author":"Fogel","year":"2018","journal-title":"Contemp Clin Trials Commun"},{"key":"10.1016\/j.oret.2024.05.014_bib12","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.3346\/jkms.2018.33.e213","article-title":"Real-world evidence versus randomized controlled trial: clinical research based on electronic medical records","volume":"33","author":"Kim","year":"2018","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1016\/j.oret.2024.05.014_bib13","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s12325-018-0805-y","article-title":"Interpretation and impact of real-world clinical data for the practicing clinician","volume":"35","author":"Blonde","year":"2018","journal-title":"Adv Ther"},{"key":"10.1016\/j.oret.2024.05.014_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s40123-017-0087-5","article-title":"A\u00a0systematic review of the treat and extend treatment regimen with anti-VEGF agents for neovascular age-related macular degeneration","volume":"6","author":"Gemenetzi","year":"2017","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.oret.2024.05.014_bib15","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.3332\/ecancer.2022.1476","article-title":"Audit of screen failure in 15 randomised studies from a low and middle-income country","volume":"16","author":"Parekh","year":"2022","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.oret.2024.05.014_bib16","doi-asserted-by":"crossref","first-page":"642","DOI":"10.4103\/crst.crst_157_21","article-title":"Post hoc analysis of the screening log of phase III investigator-initiated randomized clinical trial comparing palliative oral metronomic versus intravenous chemotherapy in head-and-neck cancer","volume":"4","author":"Dhumal","year":"2021","journal-title":"Cancer Res Stat Treat"},{"key":"10.1016\/j.oret.2024.05.014_bib17","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.21037\/atm-21-5010","article-title":"Analysis of the reasons for screening failure in phase I clinical trials in China: a retrospective study of the clinical trials screening process","volume":"9","author":"Li","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.oret.2024.05.014_bib18","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1016\/j.clgc.2017.08.019","article-title":"Screen failure rates in contemporary randomized clinical phase II\/III therapeutic trials in genitourinary malignancies","volume":"16","author":"Wong","year":"2018","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.oret.2024.05.014_bib19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.amjcard.2021.02.022","article-title":"Reasons for screen failure for transcatheter mitral valve repair and replacement","volume":"148","author":"Forrestal","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.oret.2024.05.014_bib20","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00280-019-03801-w","article-title":"Eligibility criteria for phase I clinical trials: tight vs loose?","volume":"83","author":"Malik","year":"2019","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.oret.2024.05.014_bib21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4103\/picr.PICR_198_18","article-title":"Factors influencing recruitment and retention of participants in clinical studies conducted at a tertiary referral center: a five-year audit","volume":"11","author":"Bose","year":"2020","journal-title":"Perspect Clin Res"},{"key":"10.1016\/j.oret.2024.05.014_bib22","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/1740774514538706","article-title":"Screen failure data in clinical trials: are screening logs worth it?","volume":"11","author":"Elm","year":"2014","journal-title":"Clin Trials"},{"key":"10.1016\/j.oret.2024.05.014_bib23","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.2105\/AJPH.2013.301706","article-title":"A\u00a0systematic review of barriers and facilitators to minority research participation among African Americans, Latinos, Asian Americans, and Pacific Islanders","volume":"104","author":"George","year":"2014","journal-title":"Am J Public Health"},{"key":"10.1016\/j.oret.2024.05.014_bib24","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.oret.2023.07.015","article-title":"Racial and ethnic distribution in diabetic macular edema clinical trials in the United States (2002\u20132021)","volume":"7","author":"Yu","year":"2023","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2024.05.014_bib25","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1590\/S0102-311X2008001000020","article-title":"Informal work, unemployment and health in Brazilian metropolitan areas, 1998 and 2003","volume":"24","author":"Giatti","year":"2008","journal-title":"Cad Saude Publica"},{"key":"10.1016\/j.oret.2024.05.014_bib26","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4103\/picr.PICR_206_19","article-title":"Recruitment and retention of the participants in clinical trials: challenges and solutions","volume":"11","author":"Chaudhari","year":"2020","journal-title":"Perspect Clin Res"},{"key":"10.1016\/j.oret.2024.05.014_bib28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s12553-023-00738-2","article-title":"Artificial intelligence applied to clinical trials: opportunities and challenges","volume":"13","author":"Askin","year":"2023","journal-title":"Health Technol (Berl)"},{"key":"10.1016\/j.oret.2024.05.014_bib29","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1513\/AnnalsATS.202003-192SD","article-title":"The REMAP-CAP (randomized embedded multifactorial adaptive platform for community-acquired pneumonia) study. Rationale and design","volume":"17","author":"Angus","year":"2020","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.oret.2024.05.014_bib30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12916-018-1017-7","article-title":"Adaptive designs in clinical trials: why use them, and how to run and report them","volume":"16","author":"Pallmann","year":"2018","journal-title":"BMC Med"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246865302400263X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246865302400263X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T07:17:08Z","timestamp":1730704628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246865302400263X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S246865302400263X"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2024.05.014","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screen Failures in Clinical Trials in Retina","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2024.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}